Supported by funding from the Austrian Science Fund FWF, a team from the Max F. Perutz Laboratories deciphered the mechanism of the TTP protein as a time-switch for the programmed cell death of white blood cells. A targeted death of these cells prevents an excessive immune reaction, but could also be used as a therapeutic […] Continue reading “Time-switch for immune cells”
A group of researchers from Innsbruck has been the first to describe how damaged cells can be inhibited from multiplying further after incomplete division. In a project funded by the FWF, the team disproved the previous assumption that the mechanism is triggered by defective genetic information. Continue reading “Discovery of new mechanism for tumour suppression”
Special cholesterol-lowering drugs can hamper the growth of metastasising melanoma cells if the cellular messenger substance Interleukin-6 (IL-6) is present. This link was observed in a research project funded by the Austrian Science Fund FWF, the results of which were published in the journal “Melanoma Research”. Continue reading “Cholesterol-lowering drug can kill melanoma cells”